Ascensia Diabetes Care announced that it successfully completed its initial European launch for the Senseonics (NYSE:SENS) Eversense E3. Eversense E3 represents Senseonics’ next-generation continuous glucose monitor (CGM) system. Eversense E3 can be used for up to six months (180 days). This doubles the wear time of its previous-generation CGM. Ascensia said in a news release […]
Patient Monitoring
Analysts: Abbott, Dexcom to benefit from proposed CMS decision on CGMs
Analysts see a new proposed local coverage determination (LCD) from CMS as a potential boost for Dexcom (Nasdaq:DXCM) and Abbott (NYSE:ABT). The Centers for Medicare and Medicaid Services (CMS) yesterday published the LCD modifying coverage criteria for continuous glucose monitors (CGMs). The modification includes people with diabetes who receive insulin treatment or have a history […]
HeartBeam enables smartwatch connectivity for heart monitoring
HeartBeam (Nasdaq:BEAT) announced today that it expanded its product portfolio to add arrhythmia detection capabilities to wearables. Santa Clara, California-based HeartBeam said in a news release that it aims to serve the growing cardiac device wearable market. The pipeline advancement allows for the addition of arrhythmia detection capabilities for AFib and other arrhythmia monitoring. The […]
Study shows reduced HbA1c with Abbott FreeStyle Libre 2 CGM
Abbott (NYSE:ABT) announced today that a new study supports the use of its FreeStyle Libre 2 continuous glucose monitor (CGM). The study, published in The New England Journal of Medicine, evaluated adults with type 1 diabetes and suboptimal glycemic control. It demonstrated significant reductions in glycated hemoglobin (HbA1c) compared to self-monitoring of blood glucose. Subjects […]
Dexcom G7 launches in a handful of countries outside the U.S.
Dexcom (Nasdaq:DXCM) announced today that it made the next-generation Dexcom G7 available in a number of countries outside the U.S. The San Diego-based company now offers Dexcom G7 in the U.K., Ireland, Germany, Austria and Hong Kong. Availability covers people with diabetes aged two years and older. The launch marks the first major milestone in […]
Align Technology launches AI-powered home monitoring for Invisalign clear teeth aligners
Align Technology (Nasdaq:ALGN) announced that it launched the Invisalign Virtual Care AI remote monitoring solution. Tempe, Arizona-based Align designed the next-generation platform to streamline workflows for doctors and their staff. Features include patient enrollment, setup, and review directly on the Invisalign Doctor Site. This eliminates the need to use separate standalone solutions. Assisted by artificial […]
7 innovative digital health offerings to treat diabetes
From using your smartphone to track data to reversing your diabetes altogether, these digital health technologies stand out. Advances in treatments for diabetes never stop coming. Whether that be in the form of insulin pumps or continuous glucose monitors, we’ve seen plenty. Moving away from the physical device, innovations in the digital diabetes space continue […]
Study backs automated insulin delivery system from Diabeloop
Diabeloop today announced 12-month data supporting its hybrid closed-loop DBLG1 automated insulin delivery system. Paris-based Diabeloop evaluated DBLG1 in a large, multi-country patient cohort. Results demonstrated constant improvement in time in range and time in hypoglycemia remaining significantly low. Get the full story at our sister site, Drug Delivery Business News.
Medtronic, FDA warn on potential cybersecurity risk with MiniMed insulin pump
Medtronic (NYSE:MDT) issued an urgent medical device correction notice to warn of potential issues with some MiniMed automated insulin delivery systems. The notice — dated this month — covers the company’s MiniMed 600 series insulin pumps (MiniMed 630G and 670G). Affected devices also include the Guardian Link 3 transmitter, Contour Next Link 2.4 blood glucose […]
NIH grants Eko $2.7M to develop pulmonary hypertension AI tech
Eko announced today that it received a $2.7 million Small Business Innovation Research (SBIR) Direct Phase II grant. The National Institutes of Health’s (NIH) Department of Health and Human Services (HHS) awarded the grant. The grant will fund the development of a machine learning algorithm, according to a news release. Eko said the algorithm detects […]
Study says Abbott FreeStyle Libre reduces rate of hospitalization
Abbott (NYSE:ABT) today announce real-world data demonstrating reductions in hospitalizations associated with the FreeStyle Libre system. The RELIEF study evaluated Abbott’s FreeStyle Libre continuous glucose monitoring (CGM). The findings included the significant reduction of the rate of hospitalizations due to acute diabetes events (ADEs). This study evaluated people living with type 2 diabetes on once-daily […]